journal article·2016-06-29

Protein-Poly(amino acid) Nanocore–Shell Mediated Synthesis of Branched Gold Nanostructures for Computed Tomographic Imaging and Photothermal Therapy of Cancer

Sisini Sasidharan, Dhirendra Bahadur, Rohit Srivastava

Publisher page

Abstract

Anisotropic noble metal nanoparticles especially branched gold nanoparticles with a large absorption cross-section and high molar extinction coefficient have promising applications in biomedical field. However, sophisticated and cumbersome methodologies of synthesis along with toxic precursors pose serious concern for its use. Herein, we report the synthesis of branched gold nanostructures from protein (albumin) nanoparticles by a simple reduction method. Albumin nanoparticles were synthesized by a modified desolvation technique with poly-l-arginine (cationic poly amino acid) substituting the conventional toxic cross-linker, glutaraldehyde. In silico molecular docking was carried out to study the interaction of poly-l-arginine with albumin which revealed its binding to Pocket 1B of the A-chain of albumin. The poly-l-arginine-albumin core-shell nanoparticles of ∼100 nm in size served as a base for attachment of gold ions and its reduction to form 140 nm sized branched gold nanostructures conjugated with glutathione. These gold nanostructures exhibited near-infrared absorption λmax at 800 nm with extreme compatibility toward non cancerous (NIH 3T3), oral epithelial carcinoma (KB) cell lines, and human blood (red blood cells, platelets, and coagulation mechanisms) even up to a high concentration of 250 μg/mL. These structures demonstrated superior computed tomographic (CT) contrast ability and marked photothermal cytotoxicity on KB cells. This study reports for the first time a method to develop blood and cell compatible branched gold nanostructures from protein nanoparticles as a dual CT diagnostic and photothermal therapeutic agent.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai, 400076, India

Department of Metallurgical Engineering and Materials Science, IIT Bombay, Powai, Mumbai, 400076, India

References (64)

Show source-provided references
1. 10.3390/ijms1002044110.3390/ijms10020441 ↗
2. 10.1039/c3an36705c10.1039/c3an36705c ↗
3. 10.1002/cmmi.163810.1002/cmmi.1638 ↗
4. 10.1007/s10439-005-9002-710.1007/s10439-005-9002-7 ↗
5. 10.1039/c2ra21263c10.1039/c2ra21263c ↗
6. 10.1259/bjr/1316988210.1259/bjr/13169882 ↗
7. 10.1039/C2CS35265F10.1039/C2CS35265F ↗
8. 10.1016/j.colsurfb.2009.09.00110.1016/j.colsurfb.2009.09.001 ↗
9. 10.1038/nrd450310.1038/nrd4503 ↗
10. 10.1039/C4NR03482A10.1039/C4NR03482A ↗
11. 10.2217/nnm.12.11210.2217/nnm.12.112 ↗
12. 10.1016/j.addr.2011.03.00810.1016/j.addr.2011.03.008 ↗
13. 10.1002/smll.20100013410.1002/smll.201000134 ↗
14. 10.3390/molecules19122058010.3390/molecules191220580 ↗
15. 10.2217/nnm.14.14710.2217/nnm.14.147 ↗
16. 10.1021/am500302t10.1021/am500302t ↗
17. 10.1211/jpp.60.8.000510.1211/jpp.60.8.0005 ↗
18. 10.1016/j.rpor.2010.09.00110.1016/j.rpor.2010.09.001 ↗
19. 10.1021/am506866a10.1021/am506866a ↗
20. 10.1007/s10103-007-0470-x10.1007/s10103-007-0470-x ↗
21. 10.1039/c3ra40716k10.1039/c3ra40716k ↗
22. 10.1021/nn800442q10.1021/nn800442q ↗
23. 10.1021/cm060681i10.1021/cm060681i ↗
24. 10.1088/0957-4484/23/7/07510210.1088/0957-4484/23/7/075102 ↗
25. 10.1063/1.311664510.1063/1.3116645 ↗
26. 10.1021/nl062969c10.1021/nl062969c ↗
27. 10.1021/nl803647n10.1021/nl803647n ↗
28. 10.1039/C5NR02004B10.1039/C5NR02004B ↗
29. 10.1039/C4NR02513J10.1039/C4NR02513J ↗
30. 10.1021/am505245z10.1021/am505245z ↗
31. 10.1002/adma.20140070310.1002/adma.201400703 ↗
32. 10.1016/j.cocis.2010.12.00710.1016/j.cocis.2010.12.007 ↗
33. 10.1021/jp063711d10.1021/jp063711d ↗
34. 10.1039/b711490g10.1039/b711490g ↗
35. 10.1021/ja047846d10.1021/ja047846d ↗
36. 10.1021/nl052409y10.1021/nl052409y ↗
37. 10.1039/C4NR02648A10.1039/C4NR02648A ↗
38. 10.1021/jp805474710.1021/jp8054747 ↗
39. 10.1021/la102559e10.1021/la102559e ↗
40. 10.1039/c0cc05229a10.1039/c0cc05229a ↗
41. Irache J. M. · 2007
42. 10.1016/j.jconrel.2011.07.03110.1016/j.jconrel.2011.07.031 ↗
43. 10.1002/prot.2257010.1002/prot.22570 ↗
44. 10.1002/jcc.2133410.1002/jcc.21334 ↗
45. 10.1016/S0378-5173(03)00134-010.1016/S0378-5173(03)00134-0 ↗
46. 10.1016/S0378-5173(99)00370-110.1016/S0378-5173(99)00370-1 ↗
47. 10.1109/NANO.2015.738893210.1109/NANO.2015.7388932 ↗
48. 10.1016/j.ejps.2008.12.00610.1016/j.ejps.2008.12.006 ↗
49. 10.1016/j.ijpharm.2007.03.02810.1016/j.ijpharm.2007.03.028 ↗
50. 10.1016/j.ijpharm.2010.10.01210.1016/j.ijpharm.2010.10.012 ↗
51. 10.1016/j.nano.2007.10.02110.1016/j.nano.2007.10.021 ↗
52. 10.1002/bip.2053910.1002/bip.20539 ↗
53. 10.2147/IJN.S1505410.2147/IJN.S15054 ↗
54. Lind D. S. · J. Nutr. · 2004 · 134 · 2837S10.1093/jn/134.10.2837S ↗
55. 10.1021/ja305245g10.1021/ja305245g ↗
56. 10.3390/s9020088110.3390/s90200881 ↗
57. 10.1186/1752-153X-8-1110.1186/1752-153X-8-11 ↗
58. 10.1038/srep0438410.1038/srep04384 ↗
59. 10.3322/canjclin.33.1.4410.3322/canjclin.33.1.44 ↗
60. 10.1093/annonc/mdf28010.1093/annonc/mdf280 ↗
61. 10.1038/nbt.333010.1038/nbt.3330 ↗
62. 10.1007/s11671-009-9334-610.1007/s11671-009-9334-6 ↗
63. 10.7150/thno.1197410.7150/thno.11974 ↗
64. 10.1038/aps.2011.8210.1038/aps.2011.82 ↗